These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22702743)

  • 21. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.
    King JC; Fast PE; Zangwill KM; Weinberg GA; Wolff M; Yan L; Newman F; Belshe RB; Kovacs A; Deville JG; Jelonek M;
    Pediatr Infect Dis J; 2001 Dec; 20(12):1124-31. PubMed ID: 11740317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine.
    Cox A; Baker SF; Nogales A; Martínez-Sobrido L; Dewhurst S
    J Virol; 2015 Mar; 89(6):3421-6. PubMed ID: 25552727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing.
    Ambrose CS; Dubovsky F; Yi T; Belshe RB; Ashkenazi S
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2549-57. PubMed ID: 22410646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
    Lewis KDC; Ortiz JR; Rahman MZ; Levine MZ; Rudenko L; Wright PF; Katz JM; Dally L; Rahman M; Isakova-Sivak I; Ilyushina NA; Matyushenko V; Fry AM; Lindstrom SE; Bresee JS; Brooks WA; Neuzil KM
    Clin Infect Dis; 2019 Aug; 69(5):777-785. PubMed ID: 30481272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
    King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
    Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children.
    Heikkinen T; Block SL; Toback SL; Wu X; Ambrose CS
    Pediatr Infect Dis J; 2013 Jun; 32(6):669-74. PubMed ID: 23271441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.
    Toback SL; Levin MJ; Block SL; Belshe RB; Ambrose CS; Falloon J
    Expert Rev Vaccines; 2012 Nov; 11(11):1293-303. PubMed ID: 23151111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccinating high-risk children with the intranasal live-attenuated influenza vaccine: the Quebec experience.
    Quach C
    Paediatr Respir Rev; 2014 Dec; 15(4):340-7. PubMed ID: 25242731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
    Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial.
    Victor JC; Lewis KD; Diallo A; Niang MN; Diarra B; Dia N; Ortiz JR; Widdowson MA; Feser J; Hoagland R; Emery SL; Lafond KE; Neuzil KM
    Lancet Glob Health; 2016 Dec; 4(12):e955-e965. PubMed ID: 27746224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*.
    Sheldon EA; Jeanfreau R; Sliman JA; Charenkavanich S; Rousculp MD; Dubovsky F; Mallory RM
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1142-50. PubMed ID: 23061976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.
    Karron RA; Callahan K; Luke C; Thumar B; McAuliffe J; Schappell E; Joseph T; Coelingh K; Jin H; Kemble G; Murphy BR; Subbarao K
    J Infect Dis; 2009 Mar; 199(5):711-6. PubMed ID: 19210163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.
    Breiman RF; Brooks WA; Goswami D; Lagos R; Borja-Tabora C; Lanata CF; Londoño JA; Lum LC; Rappaport R; Razmpour A; Walker RE; Gruber WC; Forrest BD
    Vaccine; 2009 Sep; 27(40):5472-9. PubMed ID: 19616493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM; Yi T; Ambrose CS
    Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
    Nichol KL; Mendelman PM; Mallon KP; Jackson LA; Gorse GJ; Belshe RB; Glezen WP; Wittes J
    JAMA; 1999 Jul; 282(2):137-44. PubMed ID: 10411194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.
    Rudenko L; Kiseleva I; Stukova M; Erofeeva M; Naykhin A; Donina S; Larionova N; Pisareva M; Krivitskaya V; Flores J;
    Vaccine; 2015 Sep; 33(39):5110-7. PubMed ID: 26296497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial.
    Davidson LE; Fiorino AM; Snydman DR; Hibberd PL
    Eur J Clin Nutr; 2011 Apr; 65(4):501-7. PubMed ID: 21285968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
    Krishnan A; Dar L; Saha S; Narayan VV; Kumar R; Kumar R; Amarchand R; Dhakad S; Chokker R; Choudekar A; Gopal G; Choudhary A; Potdar V; Chadha M; Lafond KE; Lindstrom S; Widdowson MA; Jain S
    PLoS Med; 2021 Apr; 18(4):e1003609. PubMed ID: 33914729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live attenuated influenza vaccine tetravalent: a clinical review.
    Bandell AR; Simões EA
    Expert Rev Vaccines; 2015 Jul; 14(7):963-73. PubMed ID: 25864428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.